SyntheticMR signs collaboration agreement with Mahajan Imaging
Mahajan Imaging is one of India’s most renowned diagnostic imaging centers, and the collaboration agreement is expected to strengthen SyntheticMR’s marketing efforts in India.
Mahajan Imaging are already utilizing SyntheticMR’s solution integrated on GE scanners, sold as MAGiC, to speed up the MR workflow. Now they are adding the latest FDA-cleared quantitative imaging solution, SyMRI, to many of their clinical protocols.
“This provides a great tool for challenging clinical cases, for example screening premature children or in the follow-up of patients with neurodegenerative diseases such as dementia and Alzheimer’s,” says Dr Sriram Rajan, Head of MR research at CARING, the R&D division of Mahajan Imaging.
“CARING has also been actively working on establishing new use-cases of MAGIC outside the brain. We have a presentation on using MAGIC for Quantitative Cartilage Mapping at the European Congress of Radiology in July,” added Dr. Rajan.
“MRI waiting times are always a problem, and any technology that reduces MRI waiting and also improves machine throughput, can potentially revolutionize MR imaging as a whole. This is especially pertinent in countries such as India where reimbursement rates are low, and one as to rely on high volumes to drive equipment ROIs.” says Dr Vidur Mahajan, Head of R&D at CARING.
“We see great potential in quantitative MRI on the Indian market,” says Ulrik Harrysson, CEO at SyntheticMR. “Working together with Mahajan Imaging will further support our sales and marketing efforts in India.”
For additional information, please contact Ulrik Harrysson, CEO, SyntheticMR AB, +46 70 529 29 87 firstname.lastname@example.org or Hege Nåbo, Marketing Manager, +46 70 327 24 21 email@example.com.
SyntheticMR AB develops and markets innovative software solutions for Magnetic Resonance Imaging (MRI). SyntheticMR AB’s product SyMRI® delivers multiple contrast images and quantitative data from a single 6-minute scan. The product is available in different packages. SyMRI IMAGE supports faster MRI workflows and improved patient throughput. SyMRI NEURO delivers automatic segmentation of brain tissue, supporting objective decision support. SyMRI is CE-marked and FDA 510(k) cleared. SyMRI is a registered trademark in Europe and in the USA. SyntheticMR is listed on the Spotlight Stock Market in Stockholm, Sweden. For additional information, please visit www.syntheticmr.com.